移至主內容

Chronic pain in children: time for change

This news item is more than 2 years old.
Image

On the 20th June 2019, Cochrane members published an overview review in the PAIN Journal on the efficacy of pharmacological interventions for children with chronic pain and cancer-related pain (https://bit.ly/2MMm5UH). The overview summarises the evidence from 23 systematic reviews, including several Cochrane Library reviews from our NIHR Programme Grant (https://papas.cochrane.org/nihr-programme-grant-2014-17). This work also builds on a policy workshop we held in 2018 focussing on this topic (https://bit.ly/2RGOGcK).

 

The overview highlights the lack of available evidence across all drugs aimed at relieving pain in children (just 6 trials of 393 participants). Therefore, we have launched a large dissemination plan to share these findings. We are publishing articles, blogs, newsletters, videos, and co-ordinating a social media campaign to help us start a conversation about the importance of evidence production in children’s pain.

 

We thank everyone who has contributed to this important piece of work. Please do feel free to use these links and distribute them widely to help us improve the science, policy and practice of paediatric pain management.

 

 

Resources

 

 

 

 

 

 

 

 

  • Somerset Live: Bath Hospital Trust supports study into drug treatment of chronic pain in children (here)
  • Medical Xpress: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • News Medical (Life Sciences): Are Chronic Pain Relief Drugs for Children Effective? (here; also on Medicine News Line here; and on herenciageneticayenfermedad here); and Study reveals lack of evidence for pediatric drugs prescribed to treat chronic pain (here)
  • American News Report: Lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • EurekAlert: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • 7th Space: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • Newswise: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • Physical Therapy Products: Chronic Pain in Kids Needs to Be Studied More, Researchers Urge (here)
  • The Independent: Children’s pain is under-researched (here - scroll down to end of page)
  • Technology.org: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • BBC 1 West - BBC London News (hereherehere)
  • BBC Bristol (here)
  • Health Canal: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • Europa Press: in Spanish (here and here)
  • The Courier & Advertiser Fife edition: Pain relief for children called into question (here - Press Reader account required)
  • Health Medicine Network: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • ScienMag: Researchers Reveal Lack Of Evidence For Drugs Prescribed To Treat Chronic Pain In Children (here)
  • Science Codex: Researchers reveal lack of evidence for drugs prescribed to treat chronic pain in children (here)
  • Bioengineer.org: Researchers Reveal Lack Of Evidence For Drugs Prescribed To Treat Chronic Pain In Children (here)

 

The story continues...

In 2020, Professor Christopher Eccleston, Dr Emma Fisher, and others produced The Lancet Child and Adolescent Health Commission’s report to address paediatric pain and recommend what more can be done to help children and young people: https://www.thelancet.com/commission/paediatric-pain

More links related to the Lancet launch in October 2020:

 


And continues...

In December 2020, the WHO published Guidelines on the management of chronic pain in children: access here.

Our Cochrane Reviews contributed to the guideline and Dr Emma Fisher led the review of effectiveness.

Overview (taken from the guideline)

In these guidelines, the World Health Organization (WHO) provides evidence-informed recommendations for the management of chronic pain in children. The recommendations are based on the most current, high-quality scientific evidence, and were formulated following processes and using methods that meet the highest international standards for guideline development. The recommendations in this guideline are based on systematic reviews of the evidence on benefits, harms, acceptability and feasibility, as well as on equity and resource considerations. The recommendations were formulated by the Guideline Development Group, consisting of individuals with diverse expertise and experiences and with global representation. 

The purpose of this guideline is to assist WHO Member States and their partners in developing and implementing national and local policies, regulations, pain management protocols and best practices. It will help countries balance concerns about ensuring access to appropriate therapies for pain relief with the harms arising from misuse of medications and other potential adverse effects of interventions for pain management. 

These guidelines focus on physical, psychological and pharmacological interventions for the management of primary and secondary chronic pain in children 0 to 19 years of age.

我們對Cookie的使用

我們使用必要的 cookie 使我們的網站正常運作。我們還希望設置可選擇分析的 cookie,以幫助我們進行改進網站。除非您啟用它們,否則我們不會設置可選擇的 cookie。使用此工具將在您的設備上設置 cookie,以記住您的偏好。您隨時可以隨時通過點擊每個頁面下方的「Cookies 設置」連結來更改 Cookie 偏好。
有關我們使用 cookie 的更多詳細資訊,請參閱我們的 cookie 頁面

接受所有
配置